当前位置: X-MOL 学术Stem Cell Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Generation of induced pluripotent stem cell line RCPCMi004-A derived from patient with Parkinson's disease with deletion of the exon 2 in PARK2 gene.
Stem Cell Research ( IF 0.8 ) Pub Date : 2020-02-24 , DOI: 10.1016/j.scr.2020.101733
L D Shuvalova 1 , A V Eremeev 2 , A N Bogomazova 2 , E V Novosadova 3 , E A Zerkalenkova 4 , Yu V Olshanskaya 4 , E Y Fedotova 5 , E S Glagoleva 6 , S N Illarioshkin 5 , O S Lebedeva 2 , M A Lagarkova 2
Affiliation  

IPSC line RCPCMi004-A was generated from skin fibroblasts collected from a male patient with early onset Parkinson's disease. The patient carries a heterozygous deletion of the exon 2 of PARK2 gene. The reprogramming of fibroblasts was performed with Sendai viruses containing Oct-4, Sox-2, Klf-4 and c-Myc. Pluripotency was confirmed by immunofluorescence, RT-PCR, and formation of embryoid bodies. The RCPCMi004-A cell line carries the same deletion in PARK2 gene. The RCPCMi004-A cell line can be used to model Parkinson's disease in vitro.



中文翻译:

派生自帕金森氏病患者的诱导多能干细胞系RCPCMi004-A,其PARK2基因中的外显子2缺失。

IPSC系RCPCMi004-A是由从患有帕金森氏病的男性患者中收集的皮肤成纤维细胞产生的。该患者携带PARK2基因外显子2的杂合缺失。成纤维细胞的重编程是用含有Oct-4,Sox-2,Klf-4和c-Myc的仙台病毒进行的。通过免疫荧光,RT-PCR和类胚体的形成证实了多能性。RCPCMi004-A细胞系在PARK2基因中带有相同的缺失。RCPCMi004-A细胞系可用于体外建模帕金森氏病。

更新日期:2020-02-24
down
wechat
bug